Stockreport

BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine. The couple, Ugur Sahin and Özlem Türeci, will shift to the new company by t [Read more]